Evidence map›Paper›PMID 22384217›Full record

ArticlePloS one2012

Longitudinal tracking of human fetal cells labeled with super paramagnetic iron oxide nanoparticles in the brain of mice with motor neuron disease.

Paolo Bigini, Valentina Diana, Sara Barbera, Elena Fumagalli, Edoardo Micotti, Leopoldo Sitia, Alessandra Paladini, Cinzia Bisighini, Laura De Grada, Laura Coloca and 13 more

Abstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Toxicological Aspects of Iron Oxide Nanoparticles.Advances in experimental medicine and biology · 2022
    Article
  8. Article
  9. Review
  10. Review
  11. In vivo imaging techniques: a new era for histochemical analysis.European journal of histochemistry : EJH · 2016
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. The wobbler mouse, an ALS animal model.Molecular genetics and genomics : MGG · 2013
    Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Paolo BiginiMario Negri Institute for Pharmacological Research, Milan, Italy.
Valentina Diana
Sara Barbera
Elena Fumagalli
Edoardo Micotti
Leopoldo Sitia
Alessandra Paladini
Cinzia Bisighini
Laura De Grada
Laura Coloca
Laura Colombo
Pina Manca
Patrizia Bossolasco
Francesca Malvestiti
Fabio Fiordaliso
Gianluigi Forloni
Massimo Morbidelli
Mario Salmona
Daniela Giardino
Tiziana Mennini
Davide Moscatelli
Vincenzo Silani
Lidia Cova

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stem Cell (SC) therapy is one of the most promising approaches for the treatment of Amyotrophic Lateral Sclerosis (ALS). Here we employed Super Paramagnetic Iron Oxide nanoparticles (SPIOn) and Hoechst 33258 to track human Amniotic Fluid Cells (hAFCs) after transplantation in the lateral ventricles of wobbler (a murine model of ALS) and healthy mice. By in vitro, in vivo and ex vivo approaches we found that: 1) the main physical parameters of SPIOn were maintained over time; 2) hAFCs efficiently internalized SPIOn into the cytoplasm while Hoechst 33258 labeled nuclei; 3) SPIOn internalization did not alter survival, cell cycle, proliferation, metabolism and phenotype of hAFCs; 4) after transplantation hAFCs rapidly spread to the whole ventricular system, but did not migrate into the brain parenchyma; 5) hAFCs survived for a long time in the ventricles of both wobbler and healthy mice; 6) the transplantation of double-labeled hAFCs did not influence mice survival.

Indexed as

Amniotic FluidAmyotrophic Lateral SclerosisAnimalsBisbenzimidazoleBrainCell NucleusCell ProliferationCell SeparationCell SurvivalDisease Models, AnimalFerric CompoundsFetal Stem CellsFlow CytometryHeterozygoteHumansLightBisbenzimidazoleFerric Compoundsferric oxideMagnetite Nanoparticles

Identifiers

PMID22384217
PMCPMC3288077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.